FAP and neoplasm: Consistent with our data above (Fig. 6b), we found pre-treatment of FAP-CAR T cells significantly enhanced the efficacy of the second treatment with Meso-CAR T cells in inhibiting tumor growth (Supplementary Fig. 12a).